These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 15031611

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis.
    Ratner P, Falqués M, Chuecos F, Esbrí R, Gispert J, Peris F, Luria X, Rosales MJ.
    Int Arch Allergy Immunol; 2005 Dec; 138(4):312-8. PubMed ID: 16224195
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults.
    Gehanno P, Bremard-Oury C, Zeisser P.
    Ann Allergy Asthma Immunol; 1996 Jun; 76(6):507-12. PubMed ID: 8673684
    [Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.
    Saint-Martin F, Dumur JP, Pérez I, Izquierdo I, French Rupatadine-Rhinitis Study Group.
    J Investig Allergol Clin Immunol; 2004 Jun; 14(1):34-40. PubMed ID: 15160440
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
    Berger WE, Schenkel EJ, Mansfield LE, Desloratadine Study Group.
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS, Philip G, Lu S, Malice MP, Reiss TF, Montelukast Fall Rhinitis Investigator Group.
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
    Raphael GD, Angello JT, Wu MM, Druce HM.
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of ebastine in the control of nasal congestion associated with allergic rhinitis.
    Ratner P, Hampel F, Gispert J.
    Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):111-5. PubMed ID: 12731456
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.
    Frèche C, Leynadier F, Horak F, Hide D, Gracia FD, Goos M, Bachert C, Horvath A, Antosova E, Verrecchia M, Soussen PB.
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):304-10. PubMed ID: 12269652
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.